P01375 (TNFA_HUMAN) Homo sapiens (Human)
Tumor necrosis factor UniProtKBInterProSTRINGInteractive Modelling
233 aa; Sequence (Fasta) ;
5 identical sequences: Homo sapiens: Q5STB3; Pan troglodytes: A0A0U5J3S4, A0A663DHG4; Pan paniscus: A0A2R8ZGR1; Gorilla gorilla gorilla: G3QT76
It is possible new templates exist for this target since these models were created.
Available Structures
42 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
mTNF-alpha hTNFR1 complex |
Heteromer P19438; | 9×GOL; 1×D84; 1×NAG; | ||||
Assess | ||||||
Crystal structure of the human tumor necrosis factor in complex with golimumab Fv |
Heteromer | |||||
Assess | ||||||
Crystal structure of TNF alpha complexed with a poxvirus MHC-related TNF binding protein |
Heteromer Q9DHW0; | 9×NAG; | ||||
Assess | ||||||
Crystal structure of TNFalpha in complex with Adalimumab Fab fragment |
Heteromer | |||||
Assess | ||||||
Complex between human TNF alpha and Llama VHH3 |
Heteromer | |||||
Assess | ||||||
Trimer-to-Monomer Disruption of Tumor Necrosis Factor-alpha (TNF-alpha) by unnatural alpha/beta-pep… |
Heteromer | 3×EDO; 1×NH2; | ||||
Assess | ||||||
Trimer-to-Monomer Disruption of Tumor Necrosis Factor-alpha (TNF-alpha) by alpha-peptide-3 |
Heteromer | |||||
Assess | ||||||
Selection of a novel highly specific TNFalpha antagonist: Insight from the crystal structure of the… |
Heteromer P05452; | 1×MG; | ||||
Assess | ||||||
TNFalpha-certolizumab Fab |
Heteromer | |||||
Assess | ||||||
Crystal structure of TNF-TNFR2 complex |
Heteromer P20333; | 3×CO; | ||||
Assess | ||||||
Structure of human Tumor Necrosis Factor (TNF) in complex with the Llama VHH1 |
Heteromer | |||||
Assess | ||||||
Crystal structure of TNF-alpha in complex with Infliximab Fab fragment |
Heteromer | |||||
Assess | ||||||
Human SIRT2 in complex with myristoylated peptide (TNF-alphaK20myr) |
Heteromer Q8IXJ6; | 1×ZN; | ||||
Assess | ||||||
CONFORMATIONAL CHANGES IN THE (ALA-84-VAL) MUTANT OF TUMOR NECROSIS FACTOR | homo-6-mer | |||||
Assess | ||||||
Crystal Structure of TNF-alpha with a small molecule inhibitor | homo-4-mer | 2×307; | ||||
Assess | ||||||
HUMAN TNF-ALPHA IN COMPLEX WITH 2-[5-(3-chloro-4-{[(1R)-1-(2-fluorophenyl)ethyl]amino}quinolin-6-yl… | homo-3-mer | 1×VGY; 1×GOL; | ||||
Assess | ||||||
asymmetric hTNF-alpha | homo-3-mer | 1×A7G; | ||||
Assess | ||||||
TUMOR NECROSIS FACTOR ALPHA, R31D MUTANT | homo-3-mer | |||||
Assess | ||||||
asymmetric hTNF-alpha | homo-3-mer | 1×D84; | ||||
Assess | ||||||
THE STRUCTURE OF TUMOR NECROSIS FACTOR-ALPHA AT 2.6 ANGSTROMS RESOLUTION. IMPLICATIONS FOR RECEPTOR… | homo-3-mer | |||||
Assess | ||||||
Asymmetric hTNF-alpha | homo-3-mer | 1×CL; 1×A6Y; | ||||
Assess | ||||||
Asymmetric hTNF-alpha | homo-3-mer | 1×MRD; 1×A7M; | ||||
Assess | ||||||
TNFR1 selectve TNF mutant; R1-6 | homo-3-mer | 1×GOL; | ||||
Assess | ||||||
Asymmetric hTNF-alpha | homo-3-mer | 1×A7A; | ||||
Assess | ||||||
Crystal Structure of TNFalpha with indolinone compound 9 | homo-3-mer | 1×UTV; | ||||
Assess | ||||||
Crystal Structure of TNFalpha with indolinone compound 11 | homo-3-mer | 1×UTY; | ||||
Assess | ||||||
TNF Receptor Subtype One-selective TNF Mutant with Antagonistic Activity | homo-3-mer | |||||
Assess | ||||||
Crystal Structure of TNFalpha with isoquinoline compound 4 | homo-3-mer | 1×UTM; | ||||
Assess | ||||||
Crystal Structure of TNFalpha with isoquinoline compound 2 | homo-3-mer | 2×UTJ; | ||||
Assess | ||||||
TNF Receptor Subtype One-selective TNF Mutant with Antagonistic Activity; R1antTNF-T8 | homo-3-mer | |||||
Assess | ||||||
Crystal Structure of Spin-Labeled T77C TNFa | homo-3-mer | 3×MTN; | ||||
Assess | ||||||
Complex between human TNF alpha and Llama VHH2 | homo-3-mer | |||||
Assess | ||||||
HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT | homo-3-mer | |||||
Assess | ||||||
Crystal structure of human NGR-TNF | homo-3-mer | |||||
Assess | ||||||
Crystal Structure of TNFalpha with fragment compound 6 | homo-3-mer | 2×UTS; | ||||
Assess | ||||||
HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT | homo-3-mer | |||||
Assess | ||||||
Human TNFa dimer in complex with the semi-synthetic bicyclic peptide M21 | homo-2-mer | 4×GOL; 1×38A; | ||||
Assess | ||||||
HUMAN TNF-ALPHA IN COMPLEX WITH JNJ525 | homo-2-mer | 2×JNI; | ||||
Assess | ||||||
Transmembrane helix of tumor necrosis factor alpha in trifluorethanol | monomer | |||||
Assess | ||||||
Transmembrane helix of tumor necrosis factor alpha in trifluorethanol, AGALLL mutant | monomer | |||||
Assess | ||||||
Transmembrane helix of tumor necrosis factor alpha in trifluorethanol, S34P mutant | monomer | |||||
Assess | ||||||
Conformational ensemble of solnatide in solution | monomer | |||||
Assess |
2 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
2e7a.1.A | homo-3-mer | 0.80 | 92.36 | |||
Assess | ||||||
7atb.1.A | monomer | 0.67 | 90.63 | |||
Assess |